PRED Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 13:15):

Stats
Today's Volume	20 000.00
Average Volume	39 262.00
Market Cap	149 798
EPS	$-0.0200 ( 2021-05-17 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2021-04-09	Dey Michael	Buy	1 500 000	Common Stock Options
2021-04-09	Barhorst Ronald	Buy	1 500 000	Common Stock Options
2021-04-09	Robinson Bradley C	Buy	4 000 000	Common Stock Options
2021-04-09	Hatch Orrin	Buy	250 000	Common Stock Options
2021-04-09	Evans Paul S	Buy	250 000	Common Stock Options

INSIDER POWER
0.00
Last 28 transactions
Buy: 18 260 000 \| Sell: 7 200 000

Predictive Technology Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Predictive Technology Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q1	2024
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q4	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Predictive Technology

Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditions; and regenerative medicine products, including AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte for use in regenerative medicine applications. It has a collaboration agreement with Atrin Pharmaceuticals LLC to develop molecular diagnostic tools to facilitate enhanced selection of cancer patients. The company was formerly known as Global Enterprises Group, Inc. and changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group, Inc. was founded in 2005 and is headquartered in Salt Lake City, Utah.